(Q73093126)

English

5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group

scientific article published on 01 August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Evaristo Maiello

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

V Gebbia

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Giuliani

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Paoletti

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

N Gebbia

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Cigolari

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Fortunato

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Pedicini

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

N Borsellino

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Lopez

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Colucci

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1045-1051

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Which 5-fluorouracil regimen?--the great debate.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Topoisomerases, new targets in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of irinotecan in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

CPT-11 (Irinotecan) in the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342928408

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008342928408

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038044%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73093126&oldid=1756080341"